Navigation Links
New treatment combination proves safe for head and neck cancer patients
Date:5/30/2009

PITTSBURGH, May 30 Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan Argiris, M.D., associate professor of medicine, University of Pittsburgh School of Medicine, and co-leader of the Head and Neck Cancer Program of the University of Pittsburgh Cancer Institute (UPCI). The results will be disclosed at the 45th annual meeting of the American Society of Clinical Oncology (ASCO) on May 30 in Orlando, Fla.

"We found that adding gefinitib to standard chemotherapy was well-tolerated by patients who had already received chemotherapy or were frail," said Dr. Argiris. "We had hoped this study would improve the survival rate of patients, but while gefinitib did postpone spread of the disease, it did not increase survival rates. The finding that the addition of gefinitib to chemotherapy can delay the growth of head and neck cancer suggests a potential beneficial effect from combination therapy."

One group of 136 patients in the placebo-controlled study received docetaxel alone, a standard treatment for head and neck cancer. A second group of 134 patients received gefinitib in addition to docetaxel. This was the first phase III randomized trial to examine the addition of gefinitib to chemotherapy for patients with head and neck cancer. Gefinitib, which also is known by the trade name Iressa, is a targeted therapy against the epidermal growth factor receptor (EGFR) with fewer side effects than traditional chemotherapies. Patients were able to take the drug orally and tolerated it well.

Dr. Argiris plans to conduct further studies to identify the subsets of patients most likely to respond to the drug and to examine patients' quality of life while taking the combination therapy.

Head and neck cancers are a group of biologically similar cancers originating from the upper
'/>"/>

Contact: Courtney McCrimmon
McCrimmonCP@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Better treatment selection and improved therapies -- key to improving prognosis in acute HF
2. Individualized treatment for heart failure is rarely available outside hospital
3. Minimally invasive stroke treatment produces better patient outcomes than surgical operation
4. Researchers develop light-treatment device to improve sleep quality in the elderly
5. New Fast and Precise Treatment Planning System Among Varian Medical Systems Highlights at American Brachytherapy Society 2009 Meeting
6. Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (Pink Eye)
7. Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook
8. Miracle Treatment for Burn Scars as Seen on Today Show Will Also Be Featured on The Insider Tonight
9. Window for Stroke Treatment Opens Wider
10. New treatment option for patients with chronic hepatitis C
11. Process for Planning Safe Pain Treatment Outlined in Presentation at FDA Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... New York, New York (PRWEB) August 29, 2014 ... died from cardiac arrest following a series of dialysis ... that alleges her death was the result of ... Liebhard LLP reports. The family’s lawsuit, which was file ... 2014, claims that the use of the products resulted ...
(Date:8/29/2014)... 2014 A team of experts from ... on its way to the 2014 National Safety Council ... Center to exhibit and demonstrate a suite of healthy ... environments. Etymotic’s safety earphones and high-definition earplugs are expected ... the show. , The company’s HD5 high-definition, noise-isolating ...
(Date:8/29/2014)... 2014) A team of scientists from the University ... discovery of a process to expand production of stem ... have implications that extend beyond cancer, including treatments for ... an article published Aug. 29 in ... Center for Regenerative Medicine and Stem Cell Biology and ...
(Date:8/29/2014)... D.C. (PRWEB) August 29, 2014 Today, ... Community Anti-Drug Coalitions of America (CADCA) , the nation’s ... in response to President Obama’s intent to nominate Michael ... , “CADCA strongly supports President Obama’s decision to nominate ... is the ideal person to hold this important position ...
(Date:8/29/2014)... According to the Chicago Tribune, ... next month for medical marijuana, regulators, businesses, cultivators, ... as a legalized medicine. New marijuana policies address ... to operate in accordance with local government, as ... to handle legal cannabis. , Restrictions concerning ...
Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:Etymotic’s Safe Listening Earphones and Earplugs Headed For The 2014 NSC Safety Expo 2Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:CADCA Statement on Nomination of Michael Botticelli as U.S. Drug Czar 2Health News:Medical Marijuana Approaches Legalization in Chicago 2
... , NEW YORK, Sept. 22 Reportlinker.com ... in its catalogue. , , ... and Healthcare Transaction Processing, 3rd Edition , The ... , , The North American market ...
... News media and scientists interested in finance, entrepreneurships and ... Chemical Society (ACS) Small & Medium Business Webinar on ... ) Small Business Innovation Research (SBIR) priority funding ... 24, 2 3 p.m. Eastern Time, the webinar ...
... think the air outside is polluted, a new research report ... ( http://www.genetics.org ) might make you to think twice ... show how about 3 percent of the air we breathe ... Specifically, these superoxides lead to the creation of a toxic ...
... BRYAN, Ohio, Sept. 22 For most ... more and more children are diagnosed with allergies and intolerances to ... leave many kids feeling left out. Spangler Candy Company ... inviting kids back in on all the fun. , , ...
... , MERRIAM, Kan., Sept. 22 ... . ." t-shirts to be auctioned off to benefit Christina ... National Denim Day on October 2, one of the largest single ... To view the Multimedia News Release, go to: ...
... CEDAR KNOLLS, N.J., Sept. 22 ScienceFirst is ... as a result of ScienceFirst,s sustained annual growth. , ... senior account director at ScienceFirst, where he will be ... delivery. Before joining ScienceFirst, Steen held the position of ...
Cached Medicine News:Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 2Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 3Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 4Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 5Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 6Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 7Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 8Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 9Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 10Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 11Health News:New research provides new insight into age-related muscle decline 2Health News:Spangler Helps Children with Food Allergies and Intolerances Enjoy a Worry-Free Halloween 2Health News:Video: Celebrities Join Christina Applegate to Share Their Heart for Breast Cancer Awareness 2Health News:Video: Celebrities Join Christina Applegate to Share Their Heart for Breast Cancer Awareness 3Health News:Video: Celebrities Join Christina Applegate to Share Their Heart for Breast Cancer Awareness 4
(Date:8/29/2014)... 29, 2014 Thoratec Corporation (NASDAQ: ... support therapies to save, support and restore failing hearts, ... Morgan Stanley Global Healthcare Conference on Wednesday, September 10. ... Chief Executive Officer, will provide an update on the ... a.m., Pacific Daylight Time).   A webcast ...
(Date:8/29/2014)... WEST JORDAN, Utah , Aug. 29, 2014 /PRNewswire/ ... Imaging Solutions, has acquired Polaris Medical Imaging, a leader ... CT scanners. This strategic acquisition allows BC Technical to ... their capabilities, specifically within MR and CT modalities. ... lower cost service," said Mark Alvarez , president ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2China Orthopedic Instrument Industry Report, 2014-2017 2
... Second Generation Oxazolidinone Demonstrates Safety and Efficacy with Once-Daily, ... of Treatment , , SAN DIEGO, June ... its Phase 2 clinical trial evaluating the safety and ... the treatment of severe complicated skin and skin structure ...
... sets to be released-- , , PARIS, ... in patients with blepharospasm and cervical dystonia -- one placebo-controlled ... presented at the Movement Disorder Society (MDS) 13th annual International ... Pharmaceuticals, which plans to file a Biologic License Application (BLA) ...
Cached Medicine Technology:Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 2Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 3Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 4Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting 2Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting 3Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting 4
... 25,000 units Penicillin/25,000 ... Cell Culture Reagent and ... in accordance with cGMP ... culture tested to assure ...
Penicillin-Streptomycin-Glutamine (100X) liquid...
Penicillin-Streptomycin liquid...
... combination of penicillin and streptomycin which ... and gram negative bacteria when used ... I.U. Penicillin/100,000 g/mL Streptomycin per liter. ... water at concentrations of 5,000 I.U. ...
Medicine Products: